Vascular endothelia growth factor targeted therapy may improve the effect of dendritic cell-based cancer immune therapy

Int J Clin Pharmacol Ther. 2014 Jan;52(1):76-7. doi: 10.5414/CPXCES13EA02.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Randomized Controlled Trial

MeSH terms

  • Brain Neoplasms / therapy*
  • Dendritic Cells / immunology*
  • Glioblastoma / therapy*
  • Humans
  • Immunotherapy*
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors*

Substances

  • Vascular Endothelial Growth Factor A